PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Registry for Advanced Endoscopy
- Status
- RECRUITING
- Phase
- N/A
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
- Status
- RECRUITING
- Phase
- N/A
Molecular Epidemiology of Biliary Tree Cancers
- Status
- RECRUITING
- Phase
- N/A
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- NA
Milademetan in Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
- Status
- WITHDRAWN
- Phase
- N/A
Deep Liver Phenotyping and Immunology Study
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
- Status
- UNKNOWN
- Phase
- N/A
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1